Pharmaceutical industry overview
The economic slowdown, growing demand, and constant need for innovation have prompted pharmaceutical companies to expand into new product categories and market segments. Staying ahead of technological developments in this industry is crucial and requires access to sophisticated methodologies and in-depth market data essential for business success.
Infiniti Research has extensive experience working with leading healthcare and pharma companies. Some of the research projects we have conducted for our clients in the pharmaceutical industry include patient satisfaction and feedback analysis, new product development research, product evaluation, product positioning, market segmentation research, and market opportunity analysis. Our solutions for the pharma industry comprise a unique combination of advanced research methodologies, technology, and domain expertise to deliver intelligence and empower clients with the actionable, precise information needed to understand market dynamics and enhance decisions.
Our pharmaceutical market intelligence solutions help our clients to focus on the needs of the growing patient population by offering detailed insights on different patient groups.
Focus areas
Biopharmaceuticals
We provide advanced pharmaceutical market intelligence solutions that deliver repeatable and sustainable results for our clients.
Clinical Trials
We offer solutions to enhance clinical trial success, designed just as precisely as the treatment it is intended to test.
KOL Research
Our expertise spans the entire KOL ecosystem, including KOL identification, KOL profiling and mapping.
Drug Discovery and Development
We offer ongoing support to enhance the drug development process right from discovery to launch.
Diagnostic Research
We employ integrated research methodologies to uncover new solutions to diagnostic challenges facing pharma companies.
Generics and Prescription Drugs
Our pharmaceutical market intelligence solutions help you get to the root of drug pricing challenges by offering in-depth, actionable insights.
Our pharmaceutical market intelligence solutions and innovative research methodologies have helped some of the world’s leading pharma companies, drug manufacturers, pharma R&D firms, and suppliers make informed decisions to drive outcomes and improve the quality of services.
Speak to one of our pharma market experts to find out how we can help you.Â
Latest insights
Agribusiness Companies are Adapting to Market Shifts. Here’s Why
With decades of experience in providing insight and strategy support, we have helped several companies operating in the agribusiness industry achieve successful results.
A New Era of Refinancing in the Chemical Industry
The extraordinary restructuring and debt buildup that had taken place in the Chemical industry from 2006 to 2008 has resulted in the industry going through a phase of refinancing, which is expected to drive consolidation over the next few years....
Building an Optimal Pricing Strategy for a Flagship SaaS Product | Pricing Research
Given the importance of pricing in driving product value, it could be said that pricing research is a vital component of a company’s pricing strategy. A clear understanding and management of consumers’ reference prices will help strengthen your overall pricing strategy.
Achieving a Go To Market Advantage in Developing Markets
Businesses without a global footprint are more likely to suffer when the local economy takes a hit. A significant benefit of expanding into emerging markets is that your company will be insulated from market fluctuations due to a well-established, global presence.
Keys to Creating a Winning eCommerce Strategy
As new establishments chip away the dominance of market leaders, multinational establishments are facing a decline in sales outside their home markets. Keeping abreast of market needs at a regional or country-level will empower you to analyze and...
Understanding Structural and Strategic Barriers to Entry in Global Markets
An existing market player might deliberately lower prices or take over a potential rival by purchasing sufficient shares to gain an edge in the market. As with other methods that further reinforce the barriers, regulators may prevent this to reduce competition.